Company Overview of Lithera, Inc.
Lithera, Inc. develops pharmaceutical and biomedical products that address medical and lifestyle indications in ophthalmology and aesthetic medicine. It offers LIPO-102, an injectable pharmaceutical product for local and selective fat reduction therapy. The company’s LIPO-102 is also used for the treatment of symptomatic exophthalmos associated with thyroid-related eye disease and the reduction of abdominal adiposity. Lithera, Inc. was founded in 2007 and is based in San Diego, California.
9191 Towne Centre Drive
San Diego, CA 92122
Founded in 2007
Key Executives for Lithera, Inc.
Lithera, Inc. Key Developments
Similar Private Companies By Industry
|Proteologics, Inc.||United States|
|Essential Resources, Inc.||United States|
|PlantGenix, Inc.||United States|
|HB Custom Media, Inc.||United States|
Recent Private Companies Transactions
December 19, 2012
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- Puerto Rico | AstraZenecaPosted: Dec 05
- San Francisco, CA | JobvertisePosted: Nov 30
- Parsippany, NJ | RGPPosted: Nov 27
Sponsored Financial Commentaries
To contact Lithera, Inc., please visit www.lithera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.